In addition to increased IL8 production from insulin resistant muscle itself, the high levels of IL8 released from IMAT in obesity may result in elevated local levels of IL8, which is associated with reduced substrate delivery, in addition to inflammation (Amir Levy et al., 2015). Here, CXCL8 is linked to obesity disorder.